Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 0.740. It has been cited 138 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.740
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →American Cancer Society Hope Foundation
Grant: MRSG-16-152-01-CCE
NCI
Grant: P30 CA013696
NCI
Grant: P30 CA054174
NCI
Grant: P30 CA068485
NCI
Grant: P30 CA196521
NCI
Grant: T32 CA009515
NCI
Grant: T32 CA203703
NCI
Grant: CA189828
NCI
Grant: CA189974
NCI
Grant: U01 CA231840
National Human Genome Research Institute
Grant: T32 HG008341
NIH NCATS
Grant: UL1 TR000445
NCI NIH HHS
Grant: UG1 CA189974
NCI NIH HHS
Grant: UG1 CA189828
NCI NIH HHS
Grant: U10 CA180888
FWCI
9.36
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals